We performed one-hour tMCAO in mice and intravenously administered Cy5-labeled VCAM-1-aptamers, Cy5-labeled control aptamers, or PBS at 6 h post-stroke (Fig. 1A). This evidence concerns the gene VCAM1 and stroke disorder.